Viokace
NDC Package 58914-112-10
Package Information
Viokace is a medication used along with a proton pump inhibitor medicine to treat people who cannot digest food normally. Marketed by Allergan, Inc., this product is identified by NDC 58914-112 and is authorized under FDA application BLA022542.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58914 - Allergan, Inc.
- 58914-112 - Viokace
- 58914-112-10 - 1 BOTTLE in 1 CARTON / 100 TABLET in 1 BOTTLE
- 58914-112 - Viokace
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58914-112-10 identifies a specific commercial package of 1 bottle in 1 carton / 100 tablet in 1 bottle of Viokace, labeled by Allergan, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Allergan, Inc. on March 01, 2012. The current certification is valid through April 30, 2022.
What are the primary indications for this medication?
This medication is used along with a proton pump inhibitor medicine to treat people who cannot digest food normally. The pancreas is an organ in your body that normally produces enzymes to help you digest food. Certain conditions, such as surgical removal of some or all of the pancreas, or chronic pancreatitis, can decrease the production or release of these enzymes into the bowel (intestine). Pancrelipase contains a mixture of digestive enzymes (from pig pancreas) to help breakdown and digest fats, starches, and proteins in food.
How is this Allergan, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58914011210. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.